Histone Modifications by Ethanol: Mechanism & Consequence

乙醇对组蛋白的修饰:机制

基本信息

  • 批准号:
    7619302
  • 负责人:
  • 金额:
    $ 33.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-05-15 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Mechanisms for the cellular and subcellular effects of ethanol are not well understood. Emerging evidence highlight the importance of histone modifications in gene expressions. We have observed that ethanol increases histone H3 acetylation selectively at Lys 9 (H3-Lys9) but not at Lys 14, 18 or 23. Strikingly, the increases were up to 10 fold and could be detected at as low as 5 mM ethanol. This was noted both in primary cultures of hepatocytes and in the liver of rats administered ethanol in vivo. Based on these promising original data it is hypothesized that 'ethanol increases histone acetylation via modulation of histone acetyl transferase (HAT) leading to transcriptional activation of specific genes' in the liver. The long term objective is to identify the mechanism of the acetylation, determine the identity of the HAT involved and investigate the association of the acetylated histone with specific DMA domains of genes affected by ethanol in the chromatin and correlate these alterations to apoptosis and liver damage. There are three specific aims: Aim 1: Determine mechanism and regulation of the histone acetylation: Role of ethanol derived phosphatidylethanol; effect of acetate versus ethanol on acetylation; its correlation to cell damage and apoptosis; role of oxidative stress in acetylation and use of selected knockout (KO) mice [ ADH1 (-/-); SOD 1(-/-); SOD-2 (-/-; )] Aim 2: Determine identity of HAT involved: Immunoprecipitation studies with HAT antibodies; differentiate HAT increase due to upregulation of expression versus its activation; use of SiRNA methodology and selected HAT KO mice (PCAF -/-; GCN5 ). Aim 3: Determine significance of the acetylation in transcriptional process: In vitro and in vivo studies; chromatin immunoprecipitation (CHIP) assays to determine site of interaction between the promoter of ADH1 gene and acetylated H3-lys9; analyze association between acetylated histone with specific DMA domains of selected genes (e.g. iNOS, Cyp2E1,TNFa); determine association of acetylated histone with transcription factor(s) (e.g. NFkB, p53); use of TF- protein arrays. This project deals with a new avenue in alcohol research. The data obtained on the mechanisms and consequences of histone acetylations by ethanol will be important in the construction of the 'molecular map' of ethanol induced liver injury and will help develop therapeutic tools targeting specific molecules/steps. Furthermore, study of these epigenetic changes will also have 'lateral impact1 on investigations in other cells/systems affected by ethanol.
描述(由申请人提供):乙醇的细胞和亚细胞效应机制尚未完全了解。新出现的证据强调了组蛋白修饰在基因表达中的重要性。我们已经观察到,乙醇增加组蛋白H3乙酰化选择性地在赖氨酸9(H3-赖氨酸9),而不是在赖氨酸14,18或23。引人注目的是,增加高达10倍,并可以在低至5 mM乙醇检测。这在肝细胞原代培养物和体内给予乙醇的大鼠肝脏中均观察到。基于这些有希望的原始数据,假设“乙醇通过调节组蛋白乙酰转移酶(HAT)增加组蛋白乙酰化,导致肝脏中特定基因的转录激活”。长期目标是鉴定乙酰化的机制,确定所涉及的HAT的身份,并研究乙酰化组蛋白与染色质中受乙醇影响的基因的特定DMA结构域的关联,并将这些改变与细胞凋亡和肝损伤相关联。有三个具体目标:目标1:确定组蛋白乙酰化的机制和调节:乙醇衍生的磷脂酰乙醇的作用;乙酸盐与乙醇对乙酰化的影响;其与细胞损伤和凋亡的相关性;氧化应激在乙酰化中的作用和选择性敲除(KO)小鼠的使用[ADH 1(-/-); SOD 1(-/-); SOD-2(-/-;)]目的2:确定涉及的HAT的身份:使用HAT抗体的免疫沉淀研究;区分由于表达上调与其活化引起的HAT增加;使用SiRNA方法和选择的HAT KO小鼠(PCAF -/-; GCN 5)。目标3:确定乙酰化在转录过程中的意义:体外和体内研究;染色质免疫沉淀(CHIP)测定,以确定ADH 1基因启动子与乙酰化H3-lys 9之间的相互作用位点;分析乙酰化组蛋白与选定基因的特定DMA结构域之间的关联(例如iNOS、Cyp 2 E1、TNFa);确定乙酰化组蛋白与转录因子(例如NF κ B、p53)的关联; TF-蛋白阵列的使用。该项目涉及酒精研究的新途径。乙醇组蛋白乙酰化的机制和后果所获得的数据将是重要的乙醇诱导的肝损伤的“分子图谱”的建设,并将有助于开发针对特定的分子/步骤的治疗工具。此外,对这些表观遗传变化的研究也将对受乙醇影响的其他细胞/系统的研究产生横向影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shivendra D Shukla其他文献

Shivendra D Shukla的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shivendra D Shukla', 18)}}的其他基金

Histone Modifications by Ethanol: Mechanism & Consequence
乙醇对组蛋白的修饰:机制
  • 批准号:
    7424057
  • 财政年份:
    2007
  • 资助金额:
    $ 33.31万
  • 项目类别:
Histone Modifications by Ethanol: Mechanism & Consequence
乙醇对组蛋白的修饰:机制
  • 批准号:
    7813978
  • 财政年份:
    2007
  • 资助金额:
    $ 33.31万
  • 项目类别:
Histone Modifications by Ethanol: Mechanism & Consequence
乙醇对组蛋白的修饰:机制
  • 批准号:
    8066791
  • 财政年份:
    2007
  • 资助金额:
    $ 33.31万
  • 项目类别:
Histone Modifications by Ethanol: Mechanism & Consequence
乙醇对组蛋白的修饰:机制
  • 批准号:
    7266600
  • 财政年份:
    2007
  • 资助金额:
    $ 33.31万
  • 项目类别:
Histone acetylation by ethanol:Mechanisms & consequence
乙醇乙酰化组蛋白:机制
  • 批准号:
    6911646
  • 财政年份:
    2004
  • 资助金额:
    $ 33.31万
  • 项目类别:
Histone acetylation by ethanol:Mechanisms & consequence
乙醇乙酰化组蛋白:机制
  • 批准号:
    6754225
  • 财政年份:
    2004
  • 资助金额:
    $ 33.31万
  • 项目类别:
ETHANOL AND MAP KINASE CASCADE
乙醇和 MAP 激酶级联
  • 批准号:
    2679989
  • 财政年份:
    1998
  • 资助金额:
    $ 33.31万
  • 项目类别:
Ethanol and MAP Kinase Cascade
乙醇和 MAP 激酶级联
  • 批准号:
    7007351
  • 财政年份:
    1998
  • 资助金额:
    $ 33.31万
  • 项目类别:
Ethanol and MAP Kinase Cascade
乙醇和 MAP 激酶级联
  • 批准号:
    6733950
  • 财政年份:
    1998
  • 资助金额:
    $ 33.31万
  • 项目类别:
Ethanol and MAP Kinase Cascade
乙醇和 MAP 激酶级联
  • 批准号:
    7803353
  • 财政年份:
    1998
  • 资助金额:
    $ 33.31万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 33.31万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 33.31万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 33.31万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 33.31万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 33.31万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 33.31万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 33.31万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 33.31万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 33.31万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 33.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了